The earliest stages
of the development of human beings, from conception through the period shortly
after birth, are fraught with life-and-death issues. Whether concerned about
the fate or welfare of a particular embryo, fetus or baby, or hoping to benefit
from a reproductive technology or stem cell research, countless individuals
and families in every part of the nation face difficult questions every day.
Americans hold a wide range of ethical and religious opinions about beginning-of-life
questions, and various religious denominations disagree, often sharply and vociferously,
about the correct course of action in given cases. These disagreements arise
because major religious traditions differ profoundly on the moral status of
life before birth and even on the terminology that is appropriate to use in
referring to it. For example, biological terminology uses the term embryo
for the first eight weeks after conception and fetus from then until
birth. Depending on their frame of reference, some people use these terms in
nontechnical discussions and others do not, preferring to speak of a baby from
the time of conception.
Because these disagreements
are significant and often deeply felt, issues dealing with life before birth
tend to be highly controversial. Further changes in the technologies involving
stem cell research, genetic diagnosis, assisted reproduction, and the birth
and care of extremely premature infants or ones with severe birth defects will
only raise additional contentious questions. These issues are most often played
out in real-life medical settings, and decisions concerning particular cases
and circumstances are often made in the public arena, with the policies of government
entities, insurance companies, and health care providers and institutions coming
into play, along with those of various religious groups.
Americans sometimes
confront these issues as individuals and family members – for example, when
they are affected by infertility, a troubled pregnancy, an extremely premature
birth, severe birth defects in a newborn, or when they or a relative suffer
from a disease, such as Parkinson’s or Type I diabetes, that might be helped
by treatments using stem cells. Americans also deal with these issues as citizens
when they attempt to influence law or public policy to reflect their views on
the issue.
How to use this
guide
This
guide begins by outlining major beginning-of-life issues, then divides sources
into two categories – national sources and organizations. While many of the
experts listed here can address abortion, abortion is not a significant part
of this source guide because there are so many experts and organizations that
focus on that one issue. ReligionLink plans to provide a source guide on abortion
in the future.
Click
the map for interview sources
in your state and region
If you would like
to be added to this source listing or request a change in the information, please
email bioethics@religionlink.org.
If you are requesting a change in the wording of your listing, please state
the reason for the change. ReligionLink reserves the right to decide which listings
to include.
• For organizations,
include the name, mission, Web site and a contact name with phone number and
email. Also include any specific areas of interest and expertise.
• For individuals,
include name, title, organization, Web site, areas of expertise, phone number
and email.
MAJOR
BEGINNING-OF-LIFE ISSUES
The moral status
of human life before birth. Although none dispute that, in a biological
sense, the embryo is alive and has a distinct genetic identity from the moment
of conception, major religious traditions differ on the moral status they accord
to the embryo and fetus. This profoundly influences the attitudes that they
take toward many technologies and techniques. Some traditions, especially Roman
Catholicism and some other Christian denominations, believe that the embryo
has the status of a full human person from the moment of conception. Others,
including Islam and Judaism, recognize that the embryo and fetus have the potential
for full human life, which they hold in reverence, but do not accord parity
with people who have been born. Some Christians share this view. Others believe
that human status begins at some intermediate point, as, for example, when the
fertilized ovum implants in the uterus or when the fetus is considered capable
of viability outside the womb. Within a number of larger religious traditions,
furthermore, differences exist in interpretation of the group’s larger orientation
toward the moral status before birth.
Embryonic stem
cell research. The moral status accorded to the embryo and fetus profoundly
affects how various traditions view specific techniques and technologies, such
as research on stem cells derived from embryos, which some religious groups
encourage as a potentially valuable health measure and others reject as homicide.
Assisted reproduction.
Religious traditions differ in their attitude toward techniques to assist
reproduction that involve creation or manipulation of embryos or use of donor
eggs or sperm. Some approve these methods and others forbid them.
Cloning of human
embryos. Faith communities in the United States universally reject cloning
of embryos for the purpose of producing human beings who will be born. Some
however, accept cloning for the purpose of producing products, such as stem
cells, for use in medical treatment, a process known as therapeutic cloning,
while others categorically reject the practice.
Conflict between
the welfare of the mother and of the pregnancy. Pregnancy can present medical
issues in which the health or welfare of the mother is at odds with those of
the pregnancy or of the embryo or fetus, such as when the mother has or develops
a condition that makes the pregnancy or birth a threat to her health or life.
Sometimes saving a problematic pregnancy also can require treatments that may
be detrimental to the mother. Religious traditions differ on how to weigh the
conflicting interests in such cases. Some, particularly some Christian denominations,
believe that the interests of the embryo or fetus are paramount most or all
of the time. Others, such as Judaism, believe that the life of the mother should
take precedence throughout the pregnancy and birth.
Prenatal diagnosis
and resultant abortion. Genetic and other technologies permit diagnosis
of various diseases and conditions that can threaten the life, health or normal
development of the future baby. This leads to the question of whether to terminate
the pregnancy to forestall the suffering of the child and the family if the
child is born. Some traditions forbid termination and therefore may encourage
expectant parents to forgo prenatal testing. Others permit or even encourage
these practices in order to spare a baby and family from suffering a grave or
inevitably fatal disease.
Decisions regarding
the birth and care of extremely premature babies or those with severe birth
defects. Babies born extremely premature or with severe birth defects have
a high likelihood of dying, and, should they survive, of suffering severe ailments
or disabilities. Heroic neonatal intensive care techniques are often capable
of keeping such babies alive, but, in many cases, without the assurance or possibility
of anything close to normal development. The type and degree of care that should
be given to a child whose extreme immaturity or birth defects are likely to
result in major suffering are extremely controversial, both among and within
religious groups and within the medical community. In many cases, the principles
and considerations appropriate to end-of-life care become relevant, but with
the complication that the patient is unable to express a preference.
• Rebecca
Rae Anderson is associate professor of health promotion, social and behavioral health sciences at the University of Nebraska Medical Center in Omaha. She is a board-certified genetic counselor, a member of the Social, Ethical, Legal Issues Committee of the American College of Medical Genetics and the author of Religious Traditions and Prenatal Genetic Counseling. Contact 402-559-1997, randerso@unmc.edu.
• Renee
R. Anspach is an associate professor of sociology at the University of Michigan
in Ann Arbor and author of Deciding Who Lives: Fateful Choices in the Intensive-Care
Nursery. Contact 734-763-0439, ranspach@umich.edu.
• Rabbi
J.
David Bleich is Herbert and Florence Tenzer Professor of Jewish Law and
Ethics at Cardozo Law School of Yeshiva University in New York City. He is
the co-author of Jewish Bioethics and author of Bioethical Dilemmas:
A Jewish Perspective. Contact 212-790-0294, bleich@yu.edu.
• Rabbi
Michael
J. Broyde is a law professor at Emory University School of Law in Atlanta
and academic director of Emory’s Law and Religion Program. His primary areas
of interest are law and religion, Jewish law and ethics, and comparative religious
law. His writings include “Cloning People: A Jewish Law Analysis of the Issues”
in the Connecticut Law Review (1998) and “Pre-implantation Genetic Diagnosis,
Stem Cells and Jewish Law” in Tradition: A Journal of Orthodox Jewish Thought.
Contact 404-727-7546, mbroyde@law.emory.edu.
• R.
Alta Charo is Warren P. Knowles Professor of Law & Bioethics at the
University of Wisconsin Law School in Madison. She was a member of President
Clinton’s National
Bioethics Advisory Commission, where she participated in drafting its reports
on cloning human beings. Contact 608-262-5015, racharo@wisc.edu.
• Peter
A. Clark is professor of theology and health administration, holder of the John
McShain Chair in Ethics and director of the Institute of Catholic Bioethics
at St. Joseph’s University in Philadelphia. He is a Catholic priest, an affiliated
scholar-associate at the Center for Clinical Bioethics at Georgetown University
Medical Center and bioethicist for the Mercy Health System in Philadelphia.
He wrote To Treat or Not to Treat: The Ethical Methodology Of Richard A.
McCormick, S.J., As Applied to Treatment Decisions for Handicapped Newborns.
Contact 610-660-1867, pclark@sju.edu.
• Ronald
Cole-Turner is H. Parker Sharp Professor of Theology and Ethics at Pittsburgh
Theological Seminary, author of The New Genesis: Theology and the Genetic
Revolution and co-author of Pastoral Genetics: Theology and Care at the
Beginning of Life. Contact 412-441-3304 ext. 2170, coleturn@pts.edu.
• Marilyn
E. Coors is assistant professor of bioethics and genetics in the department
of psychiatry at the University of Colorado at Denver and Health Sciences Center.
She is the author of the book The Matrix: Charting the Ethics of Inheritable
Genetic Modification and of “Therapeutic Cloning: From Consequences to Contradiction”
in the June 2002 edition of The Journal of Medicine and Philosophy. Contact
303-315-0203, Marilyn.Coors@uchsc.edu.
• Dena
Davis is a law professor at Cleveland-Marshall College of Law at Cleveland State
University in Cleveland. She also has an adjunct appointment at Case Western
Reserve University’s department of biomedical ethics. She is co-author of Notes
From a Narrow Ridge: Religion and Bioethics and author of Genetic Dilemmas:
Reproductive Technology, Parental Choices and Children’s Futures. Contact
216-687-2312, dena.davis@law.csuohio.edu.
• David
Dion DeGrazia is a philosophy professor at George Washington University
in Washington, D.C. He is the author of the book Human Identity and Bioethics
and of “Moral Status, Human Identity and Early Embryos: A Critique of the President’s
Approach” in the spring 2006 edition of TheJournal of Law, Medicine
& Ethics. Contact 202-994-6913, ddd@gwu.edu.
• Jacqueline
J. Glover is an associate professor in the departments of pediatrics and
preventive medicine and biometrics at the University of Colorado at Denver and
Health Sciences Center. She is also an associate professor in the Center for
Bioethics and Humanities, where she directs the center’s clinical ethics program
and the interdisciplinary education program. She is co-author of “Ethical issues
in treating infants with very low birth weight,” in the May 2000 issue of Seminars
in Pediatric Surgery. Contact 303-315-6093, Jackie.Glover@uchsc.edu.
• Frank
Gonzalez-Crussi was formerly head of laboratories at Chicago’s Children’s
Memorial Hospital and professor of pathology at Northwestern Medical School.
His books include On Being Born and Other Difficulties. Contact through
Writers’ Representatives LLC, 212-620-0023.
• Henry
T. Greely is Deane F. and Kate Edelman Johnson Professor of Law at Stanford
University in Stanford, Calif. He chairs the California Advisory Committee on
Human Embryonic Stem Cell Research and the steering committee for the Stanford
Center for Biomedical Ethics. He is also director of the Center for Law and
the Biosciences and the Stanford Center for Biomedical Ethics’ Program on Stem
Cells in Society. Contact 650-723-2517, hgreely@stanford.edu.
• Ruth
Levy Guyer is a visiting professor teaching courses in bioethics at Haverford
College in Haverford, Pa., and the author of Baby at Risk:The Uncertain
Legacies of Medical Miracles for Babies, Families and Society (2007).
Contact 610-896-1388, rguyer@haverford.edu.
• Dr.
John
Lantos is professor of pediatrics and associate director of the MacLean
Center for Clinical Medical Ethics at the University of Chicago. He is
co-author of Neonatal Bioethics: The Moral Challenges of Medical Innovation
and author of The Lazarus Case: Life-and-Death Issues in Neonatal Intensive
Care. Contact 773-702-6700, jlantos@peds.bsd.uchicago.edu.
• Dr.
Steven
R. Leuthner is associate professor of pediatrics and bioethics at the Health
Policy Institute of the Wisconsin College of Medicine in Milwaukee. He is the
author of “Decisions Regarding Resuscitation of the Extremely Premature Infant
and Models of Best Interest” in the April/May 2001 Journal of Perinatology
and co-author of “End-of-Life Care for Neonates and Infants: The Experience
and Effects of a Palliative Care Consultation Service” in the journal Pediatrics
(September 2001), “The Ethics of Withholding/Withdrawing Nutrition in
the Newborn” in Seminars in Perinatology (December 2003) and “Palliative
Care of the Infant with Lethal Anomalies” in the journal Pediatric Clinics
of North America (2004). Contact 414-266-6706, Leuthner@mcw.edu.
• Ruth
Macklin is a bioethics professor in the department of epidemiology and population
medicine at the Albert Einstein College of Medicine in the Bronx, N.Y. She is
the author of Surrogates & Other Mothers: The Debates Over Assisted Reproduction.
Contact 718-430- 3574, Macklin@aecom.yu.edu.
• Mary
Briody Mahowald is professor emerita of obstetrics and gynecology and a
faculty member at the MacLean Center for Clinical Medical Ethics at the University
of Chicago. Her books include Women and Children in Health Care: An Unequal
Majority and Bioethics and Women: Across the Life Span. Contact
737-702-9300, mm46@uchicago.edu.
• Mary
Anderlik Majumder is assistant professor of medicine with the Center for Medical Ethics and Health Policy at Baylor College of Medicine. She is co-editor of Genetic Ties and the Family: The Impact of Paternity Testing on Parents and Children. Contact713-798-3511, majumder@bcm.edu.
• Laurence B. McCullough is professor of medicine and medical ethics and a core faculty member at the Center for Medical Ethics and Health Policy at Baylor College of Medicine in Houston. He is the author of “Neonatal Ethics at the Limits of Viability” in the October 2005 issue of the journal Pediatrics and is co-author of the book Ethics in Obstetrics and Gynecology. Contact 713-798-3505, mccullou@bcm.tmc.edu.
• Glenn
McGee holds the John A. Balint Endowed Chair in Medical Ethics and is a
professor of medicine and director of the Alden
March Bioethics Institute at Albany Medical College in New York state.
He is the author of The Perfect Baby: A Pragmatic Approach to Genetics
and editor of Who Owns Life? and The Human Cloning Debate. Contact 518-262-6082, glenn.mcgee@bioethics.net.
• Dr. William
Meadow is professor of pediatrics, assistant director of the McLean
Center for Clinical Medical Ethics at the University of Chicago and co-author
of Neonatal Bioethics: The Moral Challenges of Medical Innovation. Contact
773-702-6210, wlm1@uchicago.edu.
• Maxwell
Mehlman is professor of bioethics and professor of law at Case Western Reserve
University School of Medicine in Cleveland. He is co-author of Genetics:
Ethics, Law and Policy and author of Wondergenes: Genetic Enhancement
and the Future of Society. Contact 216-368-3983, mjm10@case.edu.
• Dr. Geoffrey
Miller is professor of pediatrics and neurology at Yale University in New
Haven, Conn. He wrote Extreme Prematurity: Practices, Bioethics and the
Law (2007). Contact 203-785-5708, geoffrey.miller@yale.edu.
• Thomas
H. Murray is president of The Hastings Center. He is author of The Worth
of a Child and co-editor of the Encyclopedia of Ethical, Legal and Policy
Issues in Biotechnology and Genetic Ties and the Family: The Impact of
Paternity Testing on Parents and Children. Contact 845-424-4040 ext. 201,
murrayt@thehastingscenter.org.
• Dr. Robert
D. Orr is professor of bioethics at The Union Graduate College-Mount Sinai
School of Medicine Bioethics Program, professor of family medicine at the University
of Vermont College of Medicine and clinical ethicist at Fletcher Allen Health
Care in Burlington, Vt. He has been vice president of the American Society
for Bioethics and the Humanities. Contact 802-847-2000, b.j.orr@comcast.net.
• Winifred J. Ellenchild Pinch is a professor at the Center for Health Policy and Ethics and professor of nursing at Creighton University in Omaha, Neb. She wrote When the Bough Breaks: Parental Perceptions of Ethical Decision-Making in NICU. Contact 402-280-2042, wpinch@creighton.edu.
• Rabbi
Avram
Reisner is adjunct professor of Rabbinics at Baltimore Hebrew University.
He is a member of the Committee on Jewish Law and Standards of the Rabbinical
Assembly and of its Subcommittee on Biomedical Ethics, and he wrote “Peri-
and Neo-Natology: The Matter of Limiting Treatment.” Contact 410-578-6900, avramreisner@netscape.net.
• John
A. Robertson holds the Vinson & Elkins Chair at the University of Texas
School of Law at Austin. His books include The Rights of the Critically Ill
and Children of Choice: Freedom and the New Reproductive Technologies.
He is chairman of the Ethics Committee of the American Society for Reproductive
Medicine. Contact 512-232-1307, jrobertson@mail.law.utexas.edu.
• Bonnie
Steinbock is a philosophy professor at the University at Albany, State University
of New York. She is also a faculty member of the Alden March Bioethics Institute
at Albany Medical College and the Union Graduate College-Mount Sinai School
of Medicine bioethics program. Steinbock wrote Life Before Birth: The Moral
and Legal Status of Embryos and Fetuses, and she edited Legal and Ethical
Issues in Human Reproduction and The Oxford Handbook of Bioethics
(2007). Contact 518-442-4262, steinbock@albany.edu.
• Carson
Strong is professor of human values and ethics at the University of Tennessee
College of Medicine in Memphis. He wrote Ethics in Reproductive and Perinatal
Medicine: A New Framework. Contact 901-448-5700, cstrong@utmem.edu.
• Carol
Tauer is professor of philosophy emerita at the College of St. Catherine
in St. Paul, Minn., and is currently visiting professor at the Center for Bioethics
of the University of Minnesota. She served on the National Institutes of Health’s
Human Embryo Research Panel, which made ethical recommendations for federal
funding of research on infertility, pre-implantation diagnosis and stem cell
research, and on the Committee on Ethics of the American College of Obstetricians
and Gynecologists. Contact 612-625-1610, tauer007@umn.edu.
• Dr. Jon E. Tyson is a professor of pediatrics and director of the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Medical School at Houston. He is the author of “Evidence-Based Ethics and the Care of Premature Infants” in the spring 1995 issue of the journal The Future of Children. Contact 713-500-5651, Jon.E.Tyson@uth.tmc.edu.
MUSLIM • The
Islamic Medical
Association of North America in Lombard, Ill., has a code of medical
ethics that includes a discussion
of beginning-of-life issues, including stem cells, cloning and assisted
reproduction. Dr. Hossam M. Fadel is chairman of the ethics committee.
Shiraz Malik is executive director. Contact 630-932-0000,
hq@imana.org.
• Abdulaziz
A. Sachedina is a coordinator of the Islamic bioethics group of the International
Association of Bioethics and is a professor of Islamic and Shiite studies
at the University of Virginia in Charlottesville. Contact 434-924-6725,
Sachedina@virginia.edu.
Georgetown
University is the nation’s oldest Catholic and Jesuit university. A pioneering
bioethics institution, Georgetown has trained many of the most pre-eminent contemporary
bioethicists. It is home to:
• the Kennedy
Institute of Ethics, the oldest academic bioethics center (see its scholars);
• the National
Bioethics Library;
• the National
Reference Center for Bioethics Literature, the world’s largest collection
of information on biomedical ethics;
• The National
Information Resource on Ethics and Human Genetics, funded by the National
Human Genome Research Institute of the National Institutes of Health;
• The Center
for Clinical Bioethics, established in 1991 at Georgetown University Medical
Center as a university-based bioethics resource for those who shape and give
health care. Contact 202-687-0100.
• The
Hastings
Center, an independent research institution in Garrison, N.Y., is a national
leader in research into ethical issues in all aspects of health care. Deputy
director Nancy Berlinger is an expert in end-of-life issues. Contact press officer
Gregory Kaebnick, 845-424-4040 ext. 227, kaebnickg@thehastingscenter.org.
• Tuskegee
University’s National
Center for Bioethics in Research and Health Care was established in January
1999 as a partial response to the apology of President Clinton for the U.S.
Public Health Service’s syphilis study conducted at Tuskegee, Ala., from 1932
to 1972. The center addresses ethical issues in science, technology and health,
with an emphasis on effects among people of color and other minorities. Contact
334-724-4612, bioethics@tuskegee.edu.
• The University
of Minnesota Center for Bioethics has 15 full- and part-time faculty. Associate
Director Dianne
Bartels is an expert in end-of-life care issues. Contact the center, 612-624-9440,
bioethx@umn.edu.
• The University
of Pennsylvania Center for Bioethics in Philadelphia is the pre-eminent
bioethics center in the United States, with more than 20 faculty members, led
by Arthur Caplan. It opened in 1994 and is devoted to teaching and research.
The center’s staff
includes experts in philosophy, medicine, law, anthropology, sociology and religion.
Its Web site is an
excellent place to start an exploration of any bioethics topic and is also home
to The American
Journal of Bioethics. Contact 215-898-7136.